A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view.
Horowski
R
R
NeuroBiotec GmbH, Berlin, Germany. r.horowski@neurobiotec.com
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology* / Q000627:therapeutic use*; D049673:History, 20th Century; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D009452:Neuroendocrinology / Q000266:history; D009480:Neuropharmacology / Q000266:history*; D009490:Neurosecretory Systems / Q000378:metabolism* / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*
D018491:Dopamine Agonists; D004298:Dopamine